CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to KYTX

Standard of Care Treatment

Phase 3
Kyverna Therapeutics, Inc. (KYTX)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Sep '27
KYTXPhase 3

Standard of Care Treatment Phase 3 Est. Readout

Standard of Care Treatment
Sep 2027~STALE
CT.gov
00%
Competitive Landscape

0 competitors in Myasthenia Gravis

View Full Landscape
Drug Information

Target Indication

Myasthenia Gravis

Clinical Trial

NCT06193889

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.